FDA Accepts sNDA for Jardiance as Potential Treatment for Chronic Kidney Disease
January 26, 2023 02:12pm
By Ashley Gallagher, Assistant Editor
Retina Risk aims to help patients identify their own personal risk scores for retinopathy, which their providers could recommend them to use.
One of the biggest problems for patients with
are microvascular (i.e., neuropathy, retinopathy, neuropathy) and macrovascular events (e.g., cardiovascular events). The American Diabetes Association recommends routine monitoring to identify patients at high risk for these complications and to prevent them from becoming a large issue for patients care. These include doing blood work, foot exams, and seeing an optometrist for screenings. Nonetheless, it is easy for patients and providers to miss appointments or identify patients at high risk.
Digital health and technology help patients and providers to better manage chronic conditions like diabetes. These days, there are a number of companies offering services that use technology to help empower patients to live healthier lives. In turn, providers have access to more electronic tools to analyze data to help them with their clinical decision-making process.
One app that designed for patients with diabetes is Retina Risk, which is available on the iOS App store and Google Play store. This app, based on the work of a team of clinicians in Iceland, aims to help patients identify their own personal risk scores for retinopathy, which their providers could recommend them to use.
For more information, view the full article atPharmacyTimes.com.